Cellebrite DI (CLBT) Acquisitions (2021 - 2025)

Cellebrite DI's Acquisitions history runs 3 years deep, the most recent figure standing at -$147.5 million for Q4 2025.

• On a quarterly basis, Acquisitions fell 2782.97% year-over-year to -$147.5 million in Q4 2025; TTM through Dec 2025 was -$164.7 million, a 1467.33% decrease from a year earlier, with the FY2025 full-year figure at $147.5 million, up 5265.94% from the prior year.
• Acquisitions eased to -$147.5 million in Q4 2025 per CLBT's latest filing, from $5.5 million in the prior quarter.
• Across five years, Acquisitions topped out at $29.3 million in Q3 2021 and bottomed at -$147.5 million in Q4 2025.
• The 3-year median for Acquisitions is -$2.9 million (2021), against an average of -$23.1 million.
• Biggest YoY gain for Acquisitions was 2782.97% in 2025; the steepest drop was 2782.97% in 2025.
• Year by year, Acquisitions stood at -$20.0 million in 2021, then soared by 127.48% to $5.5 million in 2024, then tumbled by 2782.97% to -$147.5 million in 2025.
• Per Business Quant, the three latest CLBT Acquisitions figures stand at -$147.5 million (Q4 2025), $5.5 million (Q4 2024), and -$2.7 million (Q3 2024).